Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 20564095)

1.

Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice.

Barnett CC Jr, Beck AW, Holloway SE, Kehler M, Schluterman MK, Brekken RA, Fleming JB, Silliman CC.

Cancer. 2010 Aug 15;116(16):3862-74. doi: 10.1002/cncr.25140.

2.

Accumulation of pro-cancer cytokines in the plasma fraction of stored packed red cells.

Benson DD, Beck AW, Burdine MS, Brekken R, Silliman CC, Barnett CC Jr.

J Gastrointest Surg. 2012 Mar;16(3):460-8. doi: 10.1007/s11605-011-1798-x. Epub 2012 Jan 13.

3.

Hemoglobin-based oxygen carrier mitigates transfusion-mediated pancreas cancer progression.

Lo KK, Bey EA, Patra B, Benson DD, Boothman DA, Silliman CC, Barnett CC Jr.

Ann Surg Oncol. 2013 Jun;20(6):2073-7. doi: 10.1245/s10434-012-2842-0. Epub 2013 Jan 18.

4.

The plasma fraction of stored erythrocytes augments pancreatic cancer metastasis in male versus female mice.

Moore PK, Benson D, Kehler M, Moore EE, Fragoso M, Silliman CC, Barnett CC Jr.

J Surg Res. 2010 Nov;164(1):23-7. doi: 10.1016/j.jss.2010.05.047. Epub 2010 Jun 13.

5.

The acellular fraction of stored platelets promotes tumor cell invasion.

Dineen SP, Roland CL, Toombs JE, Kelher M, Silliman CC, Brekken RA, Barnett CC Jr.

J Surg Res. 2009 May 1;153(1):132-7. doi: 10.1016/j.jss.2008.04.013. Epub 2008 May 7.

PMID:
18541268
6.

Transfusion of stored autologous blood does not alter reactive hyperemia index in healthy volunteers.

Berra L, Coppadoro A, Yu B, Lei C, Spagnolli E, Steinbicker AU, Bloch KD, Lin T, Sammy FY, Warren HS, Fernandez BO, Feelisch M, Dzik WH, Stowell CP, Zapol WM.

Anesthesiology. 2012 Jul;117(1):56-63. doi: 10.1097/ALN.0b013e31825575e6.

7.

Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.

Tanaka S, Pero SC, Taguchi K, Shimada M, Mori M, Krag DN, Arii S.

J Natl Cancer Inst. 2006 Apr 5;98(7):491-8.

8.

B7-H3 overexpression in pancreatic cancer promotes tumor progression.

Zhao X, Li DC, Zhu XG, Gan WJ, Li Z, Xiong F, Zhang ZX, Zhang GB, Zhang XG, Zhao H.

Int J Mol Med. 2013 Feb;31(2):283-91. doi: 10.3892/ijmm.2012.1212. Epub 2012 Dec 13.

9.

A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines.

Partecke LI, Sendler M, Kaeding A, Weiss FU, Mayerle J, Dummer A, Nguyen TD, Albers N, Speerforck S, Lerch MM, Heidecke CD, von Bernstorff W, Stier A.

Eur Surg Res. 2011;47(2):98-107. doi: 10.1159/000329413. Epub 2011 Jun 30.

PMID:
21720167
10.

VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.

Hotz HG, Hines OJ, Masood R, Hotz B, Foitzik T, Buhr HJ, Gill PS, Reber HA.

Surgery. 2005 Feb;137(2):192-9.

PMID:
15674201
11.

Gender-specific transfusion affects tumor-associated neutrophil: macrophage ratios in murine pancreatic adenocarcinoma.

Benson DD, Kelher MR, Meng X, Fullerton DA, Lee JH, Silliman CC, Barnett CC Jr.

J Gastrointest Surg. 2010 Oct;14(10):1560-5. doi: 10.1007/s11605-010-1329-1. Epub 2010 Sep 11.

12.

[Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis].

Li K, Li MJ, He T, Zheng Z, Zheng XL, Qu BH, Wang Y, Duan X, Zheng YJ.

Zhonghua Yi Xue Za Zhi. 2009 Sep 15;89(34):2386-90. Chinese.

PMID:
20137690
13.

S100P promotes pancreatic cancer growth, survival, and invasion.

Arumugam T, Simeone DM, Van Golen K, Logsdon CD.

Clin Cancer Res. 2005 Aug 1;11(15):5356-64.

14.

NOV promoted the growth and migration of pancreatic cancer cells.

Cui L, Xie R, Dang S, Zhang Q, Mao S, Chen J, Qu J, Zhang J.

Tumour Biol. 2014 Apr;35(4):3195-201. doi: 10.1007/s13277-013-1418-3. Epub 2013 Nov 21.

PMID:
24258112
15.

The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.

Takiguchi S, Nishino Y, Inoue K, Ikeda M, Kataoka Y, Matsusue K, Nishiyama K, Iguchi H.

Oncol Rep. 2012 Jul;28(1):111-6. doi: 10.3892/or.2012.1757. Epub 2012 Apr 6.

PMID:
22484715
16.

Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.

Komachi M, Sato K, Tobo M, Mogi C, Yamada T, Ohta H, Tomura H, Kimura T, Im DS, Yanagida K, Ishii S, Takeyoshi I, Okajima F.

Cancer Sci. 2012 Jun;103(6):1099-104. doi: 10.1111/j.1349-7006.2012.02246.x. Epub 2012 Mar 15.

PMID:
22348348
17.

Suramin inhibits not only tumor growth and metastasis but also angiogenesis in experimental pancreatic cancer.

Bhargava S, Hotz B, Hines OJ, Reber HA, Buhr HJ, Hotz HG.

J Gastrointest Surg. 2007 Feb;11(2):171-8.

PMID:
17390169
18.

Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer.

Wei H, Li F, Fu P, Liu X.

Eur Rev Med Pharmacol Sci. 2013 Feb;17(4):436-46.

19.

Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo.

Teranishi F, Takahashi N, Gao N, Akamo Y, Takeyama H, Manabe T, Okamoto T.

Cancer Sci. 2009 Apr;100(4):770-7.

PMID:
19469020
20.

Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer.

Fujisawa T, Rubin B, Suzuki A, Patel PS, Gahl WA, Joshi BH, Puri RK.

PLoS One. 2012;7(4):e34437. doi: 10.1371/journal.pone.0034437. Epub 2012 Apr 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk